Quantcast
Viewing all articles
Browse latest Browse all 2570

New Repatha evolocumab Analyses Show Efficacy And Safety Across Risk Groups In Results Presented At ESC Congress 2016

THOUSAND OAKS Calif. Aug. 28 2016 PRNewswire Amgen NASDAQAMGN today announced data presented at the European Society of Cardiology ESC Congress 2016 showing Repatha&174; evolocumab consistently reduced lowdensity lipoprotein cholesterol LDLC in patien...

Viewing all articles
Browse latest Browse all 2570

Trending Articles